Keyphrases
DNA Damage
58%
Mutant Cells
47%
Intestinal Organoids
47%
Interkinetic nuclear Migration
37%
Valproic Acid
37%
NEK1
37%
Coupled Response
37%
Berzosertib
37%
ATR Inhibitor
37%
CHIR99021
37%
MCM2-7
37%
Response Regulator
37%
Growth Advantage
37%
Post-mitotic
37%
DNA Damage Response
37%
CDKL5
37%
New Biomarkers
37%
Lgr5+
37%
G1 Phase
37%
Functional Characterization
37%
Phosphoproteomics
37%
Intestinal Stem Cells
37%
Ubiquitin
37%
Starch Branching Enzyme
37%
Associated Proteins
37%
Valosin-containing Protein
37%
Branched Ubiquitin Chain
37%
Binder
37%
WRN Helicase
37%
Selective Killing
37%
Cancer Cells
37%
Microsatellite Instability-high (MSI-H)
37%
Proteolysis Targeting chimera (PROTAC)
37%
Phosphorylation
28%
Wnt Signaling
28%
Epithelium
28%
SCAF1
25%
Highly Sensitive
25%
Genome Maintenance
25%
RNA Polymerase II (RNAPII)
25%
Nanobody
22%
Organoids
18%
Cyst
18%
Adenomatous Polyposis Coli
18%
Clinical Trials
18%
Microsatellite Stable
16%
Branched-chain
15%
Mitosis
12%
PARP Activity
12%
Proteomic Screening
12%
Biochemistry, Genetics and Molecular Biology
Kinase
100%
Phosphotransferase
100%
DNA Damage Response
75%
DNA Damage
48%
Phosphoproteomics
40%
G1 Phase
37%
CDKL5
37%
Stem Cell
37%
MCM2
37%
Transcription
37%
P97
37%
Valosin-Containing Protein
37%
Enzyme
37%
Ubiquitin
37%
Adenomatous Polyposis Coli
37%
Cancer Cell
37%
Helicase
37%
Microsatellite Instability
37%
Proteolysis
37%
Clinical Trial
24%
Birthplace
18%
Ciliogenesis
18%
Mass Spectrometry
18%
RAD51
18%
BRCA1
18%
Tumor Suppressor Protein
18%
Cell Mutant
18%
Cell Proliferation
18%
Dynamics
18%
Homeostasis
18%
Cell Size
18%
Poly ADP Ribose Polymerase
18%
DNA Synthesis
18%
Anticancer
18%
Proteomics
18%
Microsatellite
16%
Single-Domain Antibody
12%
Stable Cell
10%
Bromodomain
10%
Leucine-Rich Repeat
9%
Cell Cycle
9%
Homologous Recombination
9%
DNA Repair
9%
Dysplasia
9%
C-Terminus
9%
Interphase
9%
Restriction Point
9%
Origin of Replication
9%
Small Intestine
9%
Elongin
9%